Edifice Health, a San Mateo, CA-based immunological health and personalized nutrition company, raised $12m in funding.
The round was led by Leaps by Bayer with participation from Paladin Capital Group, Vertical Venture Partners, Ahren Innovation Capital, Ataraxia Capital Partners, Shanda Grab Ventures, Alafi Capital, and Taisho Pharmaceutical. Seed stage investors include Human Longevity and Performance Impact Venture Fund, Longevity Incubator Fund, Summer Venture Capital, Carlyle Global Advisors, M4 Capital GmbH, and Better Food Ventures.
Leaps by Bayer’s Naveen Krishnan, MD, MPhil, and Paladin Group’s Paul Conley, PhD, will join Edifice’s Board of Directors, alongside Santosh Padki, a San Francisco-based consumer products veteran, and David Furman, PhD, Edifice Founder, Leader of the Stanford Project, and Associate Professor of Applied Artificial Intelligence in Systems and Computational Immunology of Aging at the Buck Institute for Research on Aging.
citybizlist : Washington DC : Carlyle Global Advisors and Paladin Capital Group Join $12M Funding For Edifice Health citybizlist.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from citybizlist.com Daily Mail and Mail on Sunday newspapers.
Edifice, a Healthcare Disruptor spun out of Stanford, Raises $12 Million to Reinvent Immune Health, Improve Healthspan, and Change Course of Aging
News provided by
Share this article
Share this article
SAN MATEO, Calif., April 22, 2021 /PRNewswire/ Edifice Health, a Silicon Valley emerging company in immunological health and personalized nutrition, today announced a $12 Million investment, led by
Leaps by Bayer.
Through its highly-differentiated approach, Edifice aims to harness previously unattainable insights into the root causes of chronic diseases of aging, followed by delivering highly personalized interventions to improve inflammatory and immune health, and extend healthspan.
Globally, about 71% of annual deaths are attributable to non-communicable diseases of aging, which include cancer, cardiovascular diseases, Type II diabetes, neurodegenerative disorders, and depression. According to the U.S. Centers for Disease Control (CDC), 90% of the nation s staggering $3.8